The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
June 15, 2022 at 08:49 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Pfizer Halts Enrollment In ...
